ZHANG Qi, ZHANG Yu. The Road Is Long and Difficult: Evaluation of the Phase Ⅰ Clinical Trial of Novel Small Molecule Pan-BET Inhibitor ODM-207 in Solid Tumor Patients[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 280-283. DOI: 10.12019/j.issn.1671-5144.202410048
|
Citation:
|
ZHANG Qi, ZHANG Yu. The Road Is Long and Difficult: Evaluation of the Phase Ⅰ Clinical Trial of Novel Small Molecule Pan-BET Inhibitor ODM-207 in Solid Tumor Patients[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 280-283. DOI: 10.12019/j.issn.1671-5144.202410048
|
ZHANG Qi, ZHANG Yu. The Road Is Long and Difficult: Evaluation of the Phase Ⅰ Clinical Trial of Novel Small Molecule Pan-BET Inhibitor ODM-207 in Solid Tumor Patients[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 280-283. DOI: 10.12019/j.issn.1671-5144.202410048
|
Citation:
|
ZHANG Qi, ZHANG Yu. The Road Is Long and Difficult: Evaluation of the Phase Ⅰ Clinical Trial of Novel Small Molecule Pan-BET Inhibitor ODM-207 in Solid Tumor Patients[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 280-283. DOI: 10.12019/j.issn.1671-5144.202410048
|
DownLoad: